CELH Stock Analysis: Celsius Holdings | NASDAQ
Beverages - Non-Alcoholic | NASDAQ, USA | Market Cap: 7.082m USD | 12M Return: -53.4% | US15118V2079 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 201M
EPS Trend: 19.7%
Qual. Beats: 0
Rev. Trend: 90.1%
Qual. Beats: -1
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Celsius Holdings, Inc. (CELH) is a U.S.-based beverage company that develops, manufactures, and distributes functional energy drinks and hydration products across the United States, North America, Europe, Asia Pacific, and other international markets. Its portfolio includes ready-to-drink energy beverages, on-the-go powder sticks, and nutrition and wellness products marketed under the CELSIUS, Alani Nu, and Rockstar brand names. Sub-lines include CELSIUS ESSENTIALS, formulated with amino acids, and CELSIUS Hydration, a zero-sugar powder line featuring electrolytes.
The company sells through a broad omnichannel distribution network covering direct-to-store delivery, independent distributors, supermarkets, convenience stores, drug stores, nutritional and natural food stores, fitness centers, mass merchants, club stores, vitamin specialty stores, and e-commerce platforms. Founded in 2004 and headquartered in Boca Raton, Florida, the company was originally named Vector Ventures, Inc. before adopting its current name in January 2007. As a mid-cap stock in the Consumer Staples sector, Celsius operates within the Soft Drinks & Non-alcoholic Beverages sub-industry, targeting health- and fitness-oriented consumers through a portfolio of low- and zero-sugar functional drinks.
- PepsiCo distribution partnership expands Celsius shelf space domestically
- Energy drink market share gains accelerate against Monster and Red Bull
- International expansion in Europe and Asia Pacific drives volume growth
- Alani Nu acquisition diversifies portfolio toward female consumer segment
| Net Income: 110.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 3.40 > 1.0 |
| NWC/Revenue: 27.31% < 20% (prev 43.89%; Δ -16.58% < -1%) |
| CFO/TA 0.10 > 3% & CFO 508.6m > Net Income 110.2m |
| Net Debt (56.3m) to EBITDA (232.9m): 0.24 < 3 |
| Current Ratio: 1.80 > 1.5 & < 3 |
| Outstanding Shares: last quarter (256.9m) vs 12m ago 8.33% < -2% |
| Gross Margin: 48.76% > 18% (prev 50.53%; Δ -1.77% > 0.5%) |
| Asset Turnover: 67.99% > 50% (prev 43.91%; Δ 24.08% > 0%) |
| Interest Coverage Ratio: 3.61 > 6 (EBIT TTM 195.9m / Interest Expense TTM 54.3m) |
| A: 0.16 (Total Current Assets 1.88b - Total Current Liabilities 1.04b) / Total Assets 5.17b |
| B: 0.06 (Retained Earnings 313.2m / Total Assets 5.17b) |
| C: 0.04 (EBIT TTM 195.9m / Avg Total Assets 4.48b) |
| D: 1.34 (Book Value of Equity 2.96b / Total Liabilities 2.21b) |
| Altman-Z'' = 2.95 = A |
| DSRI: 0.82 (Receivables 735.3m/490.4m, Revenue 3.05b/1.67b) |
| GMI: 1.04 (GM 50.53% / 48.76%) |
| AQI: 1.00 (AQ_t 0.62 / AQ_t-1 0.61) |
| SGI: 1.83 (Revenue 3.05b / 1.67b) |
| TATA: -0.08 (NI 110.2m - CFO 508.6m) / TA 5.17b) |
| Beneish M = -2.55 (Cap -4..+1) = A |
As of October 07, 2026, the stock is trading at USD 27.29 with a total of 4,345,944 shares traded. Over the past week, the price has changed by -1.71%, over one month by -6.90%, over three months by -16.71% and over the past year by -53.44%.
Current recommended Stop Loss: 25.70 (which is 5.8% or 1.3 ATR below the current price).
Celsius Holdings has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CELH.
- StrongBuy: 8
- Buy: 6
- Hold: 6
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 42.3 | 55% |
P/E Trailing = 121.6957
P/E Forward = 16.8634
P/S = 2.3242
P/B = 6.1551
P/EG = 0.2665
Revenue TTM = 3.05b USD
EBIT TTM = 195.9m USD
EBITDA TTM = 232.9m USD
Long Term Debt = 667.9m USD (from longTermDebt, last quarter)
Short Term Debt = 7.00m USD (from shortTermDebt, two quarters ago)
Debt = 687.6m USD (from shortLongTermDebtTotal, last quarter) + Leases 19.7m
Net Debt = 56.3m USD (calculated: Debt 687.6m - CCE 631.2m)
Enterprise Value = 7.14b USD (7.08b + Debt 687.6m - CCE 631.2m)
Interest Coverage Ratio = 3.61 (Ebit TTM 195.9m / Interest Expense TTM 54.3m)
EV/FCF = 15.43x (Enterprise Value 7.14b / FCF TTM 462.8m)
FCF Yield = 6.48% (FCF TTM 462.8m / Enterprise Value 7.14b)
FCF Margin = 15.19% (FCF TTM 462.8m / Revenue TTM 3.05b)
Net Margin = 3.62% (Net Income TTM 110.2m / Revenue TTM 3.05b)
Gross Margin = 48.76% ((Revenue TTM 3.05b - Cost of Revenue TTM 1.56b) / Revenue TTM)
Gross Margin QoQ = 48.13% (prev 48.31%)
Tobins Q-Ratio = 1.38 (Enterprise Value 7.14b / Total Assets 5.17b)
Interest Expense / Debt = 7.90% (Interest Expense 54.3m / Debt 687.6m)
Taxrate = 8.84% (12.5m / 141.6m)
NOPAT = 178.6m (EBIT 195.9m * (1 - 8.84%))
Current Ratio = 1.80 (Total Current Assets 1.88b / Total Current Liabilities 1.04b)
Debt / Equity = 0.23 (Debt 687.6m / totalStockholderEquity, last quarter 2.96b)
Debt / EBITDA = 0.24 (Net Debt 56.3m / EBITDA 232.9m)
Debt / FCF = 0.12 (Net Debt 56.3m / FCF TTM 462.8m)
Total Stockholder Equity = 2.53b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.46% (Net Income 110.2m / Total Assets 5.17b)
RoE = 4.36% (Net Income TTM 110.2m / Total Stockholder Equity 2.53b)
RoCE = 6.13% (EBIT 195.9m / Capital Employed (Equity 2.53b + L.T.Debt 667.9m))
RoIC = 4.50% (NOPAT 178.6m / Invested Capital 3.97b)
WACC = 9.40% (E(7.08b)/V(7.77b) * Re(9.61%) + D(687.6m)/V(7.77b) * Rd(7.90%) * (1-Tc(0.09)))
Discount Rate = 9.61% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 47.56 | Cagr: 3.55%
[DCF] Terminal Value 74.66% ; FCFF base≈362.0m ; Y1≈415.0m ; Y5≈610.7m
[DCF] Fair Price = 30.44 (EV 7.76b - Net Debt 56.3m = Equity 7.70b / Shares 253.0m; r=9.40% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 19.70 | EPS CAGR: 16.06% | SUE: -0.24 | # QB: 0
Revenue Correlation: 90.15 | Revenue CAGR: 40.71% | SUE: -1.44 | # QB: -1
EPS current Quarter (2026-09-30): EPS=0.34 | Chg30d=-0.84% | Revisions=-84% | Analysts=19
EPS current Year (2026-12-31): EPS=1.43 | Chg30d=-0.66% | Revisions=-87% | GrowthEPS=+6.9% | GrowthRev=+26.1%
EPS next Year (2027-12-31): EPS=1.73 | Chg30d=-0.60% | Revisions=-87% | GrowthEPS=+20.9% | GrowthRev=+8.5%
[Analyst] Revisions Ratio: -95% (up=0, down=56)